MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,567,198 | -29.4% | 475,992 | +8.8% | 0.01% | -37.5% |
| Q3 2022 | $30,564,079 | +10.0% | 437,630 | +5.7% | 0.01% | +14.3% |
| Q2 2022 | $27,791,082 | -14.6% | 413,989 | +4.6% | 0.01% | 0.0% |
| Q1 2022 | $32,536,427 | -44.0% | 395,724 | 0.0% | 0.01% | -41.7% |
| Q4 2021 | $58,049,000 | -7.7% | 395,724 | +11.3% | 0.01% | -14.3% |
| Q3 2021 | $62,918,000 | +5.9% | 355,647 | -3.3% | 0.01% | +7.7% |
| Q2 2021 | $59,437,000 | -11.0% | 367,962 | -5.7% | 0.01% | -13.3% |
| Q1 2021 | $66,817,000 | -31.9% | 390,056 | -12.6% | 0.02% | -34.8% |
| Q4 2020 | $98,067,000 | +28.2% | 446,490 | -3.1% | 0.02% | +15.0% |
| Q3 2020 | $76,476,000 | +49.5% | 460,560 | +2.8% | 0.02% | +33.3% |
| Q2 2020 | $51,151,000 | +70.9% | 448,025 | +15.0% | 0.02% | +36.4% |
| Q1 2020 | $29,937,000 | -33.9% | 389,450 | +10.9% | 0.01% | -15.4% |
| Q4 2019 | $45,258,000 | +160.3% | 351,216 | +57.4% | 0.01% | +160.0% |
| Q3 2019 | $17,385,000 | – | 223,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |